Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2013, Article ID 604860, 7 pages
http://dx.doi.org/10.1155/2013/604860
Review Article

Changing Epidemiology of Hepatocellular Adenoma in the United States: Review of the Literature

1Division of Liver Diseases, The Mount Sinai Medical Center, One Gustave Levy Place, P.O. Box 1104, New York, NY 10029-6574, USA
2Recanati/Miller Transplant Institute, The Mount Sinai Medical Center, New York, NY, USA
3Department of Pathology, The Mount Sinai Medical Center, New York, NY, USA

Received 26 November 2012; Accepted 25 January 2013

Academic Editor: Paulette Bioulac-Sage

Copyright © 2013 Charissa Y. Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [33 citations]

The following is the list of published articles that have cited the current article.

  • Sudhakar K. Venkatesh, Vishal Chandan, and Lewis R. Roberts, “Liver Masses: A Clinical, Radiologic, and Pathologic Perspective,” Clinical Gastroenterology and Hepatology, 2013. View at Publisher · View at Google Scholar
  • Christine Sempoux, Charissa Chang, Annette Gouw, Laurence Chiche, Jessica Zucman-Rossi, Charles Balabaud, and Paulette Bioulac-Sage, “Benign hepatocellular nodules: What have we learned using the patho-molecular classification,” Clinics and Research in Hepatology and Gastroenterology, 2013. View at Publisher · View at Google Scholar
  • Jie Ouyang, and Swan N. Thung, “Histopathologic Manifestations of Drug-induced Hepatotoxicity,” Clinics in Liver Disease, vol. 17, no. 4, pp. 547–+, 2013. View at Publisher · View at Google Scholar
  • Safi Dokmak, Francois Cauchy, and Jacques Belghiti, “Resection, transplantation and local regional therapies for liver adenomas,” Expert Review of Gastroenterology & Hepatology, vol. 8, no. 7, pp. 803–810, 2014. View at Publisher · View at Google Scholar
  • Takaaki Nakashima, Yukihisa Takayama, Akihiro Nishie, Yoshiki Asayama, Shingo Baba, Youichi Yamashita, Ken Shirabe, Yuichiro Kubo, Tomoyuki Hida, and Hiroshi Honda, “Hepatocellular adenoma showing high uptake of 18F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2),” Clinical Imaging, 2014. View at Publisher · View at Google Scholar
  • Mathew M. Augustine, “Epidemiology and Risk Factors of Biliary Tract and Primary Liver Tumors,” Surgical Oncology Clinics of North America, vol. 23, no. 2, pp. 171–+, 2014. View at Publisher · View at Google Scholar
  • Toshio Fukusato, Yurie Soejima, Fukuo Kondo, Masafumi Inoue, Masato Watanabe, Yoshihisa Takahashi, Tatsuya Aso, Hiroshi Uozaki, Keiji Sano, Yukihiro Sanada, and Toshiro Niki, “Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin,” Hepatology Research, 2014. View at Publisher · View at Google Scholar
  • Manuel Schlageter, Luigi Maria Terracciano, Salvatore D'Angelo, and Paolo Sorrentino, “Histopathology of hepatocellular carcinoma,” World Journal Of Gastroenterology, vol. 20, no. 43, pp. 15955–15964, 2014. View at Publisher · View at Google Scholar
  • Christine Sempoux, Charles Balabaud, and Paulette Bioulac-Sage, “Malignant transformation of hepatocellular adenoma,” Hepatic Oncology, vol. 1, no. 4, pp. 421–431, 2014. View at Publisher · View at Google Scholar
  • Nafis Shafizadeh, Gillian Genrich, Linda Ferrell, and Sanjay Kakar, “Hepatocellular adenomas in a large community population 2000–2010: Reclassification per current WHO classification and results of long-term follow-up,” Human Pathology, 2014. View at Publisher · View at Google Scholar
  • Jay H. Lefkowitch, and Liza V. Antony, “The Evolving Role of Nonalcoholic Fatty Liver Disease in Hepatic Neoplasia: Inflammatory Hepatocellular Adenoma in a Man with Metabolic Syndrome,” Seminars In Liver Disease, vol. 35, no. 3, pp. 349–353, 2015. View at Publisher · View at Google Scholar
  • Safi Dokmak, and Jacques Belghiti, “Will weight loss become a future treatment of hepatocellular adenoma in obese patients?,” Liver International, 2015. View at Publisher · View at Google Scholar
  • Cristina Margini, and Jean F. Dufour, “The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment,” Liver International, vol. 36, no. 3, pp. 317–324, 2015. View at Publisher · View at Google Scholar
  • Georgios Antonios Margonis, Aslam Ejaz, Gaya Spolverato, Neda Rastegar, Robert Anders, Ihab R. Kamel, and Timothy M. Pawlik, “Benign Solid Tumors of the Liver: Management in the Modern Era,” Journal of Gastrointestinal Surgery, 2015. View at Publisher · View at Google Scholar
  • Massimo Roncalli, Amedeo Sciarra, and Luca Di Tommaso, “Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma,” Clinical and Molecular Hepatology, vol. 22, no. 2, pp. 199–211, 2016. View at Publisher · View at Google Scholar
  • Anna Simona Sasdelli, Lucia Brodosi, and Giulio Marchesini, “NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders,” Current Hepatology Reports, 2016. View at Publisher · View at Google Scholar
  • Sudhakar K. Venkatesh, Tiffany Hennedige, Geoffrey B. Johnson, David M. Hough, and Joel G. Fletcher, “Imaging patterns and focal lesions in fatty liver: a pictorial review,” Abdominal Radiology, 2016. View at Publisher · View at Google Scholar
  • Arthur Zimmermann, and Arthur Zimmermann, “Hepatocellular Adenoma,” Tumors and Tumor-Like Lesions of the Hepatobiliary Tract, pp. 443–472, 2016. View at Publisher · View at Google Scholar
  • Herwig Cerwenka, Andreas Puntschart, and Andrea Bradatsch, “Leber,” Akutes Abdomen, pp. 323–330, 2016. View at Publisher · View at Google Scholar
  • Ahmet Uygun, “Is That Possible to Stop or Cease the NASH to Turn into HCC?,” Journal of Gastrointestinal Cancer, 2017. View at Publisher · View at Google Scholar
  • Dzeina Mezale, Ilze Strumfa, Andrejs Vanags, Matiss Mezals, Ilze Fridrihsone, Boriss Strumfs, and Dainis Balodis, “Non-Alcoholic Steatohepatitis, Liver Cirrhosis and Hepatocellular Carcinoma: The Molecular Pathways,” Liver Cirrhosis - Update and Current Challenges, 2017. View at Publisher · View at Google Scholar
  • Mohammad Ali Husainy, Farhina Sayyed, and Praveen Peddu, “Typical and atypical benign liver lesions: A review,” Clinical Imaging, 2017. View at Publisher · View at Google Scholar
  • Wen-Ming Cong, Yuan Ji, Qian Zhao, Xin-Yuan Lu, Xia Sheng, Long-Hai Feng, and Yu-Yao Zhu, “Benign Tumors of the Liver and Intrahepatic Bile Duct,” Surgical Pathology of Hepatobiliary Tumors, pp. 87–144, 2017. View at Publisher · View at Google Scholar
  • F. Gryspeerdt, and R. Aerts, “Laparoscopic liver resection for hemorrhagic hepatocellular adenoma in a pregnant patient,” Acta Chirurgica Belgica, pp. 1–4, 2017. View at Publisher · View at Google Scholar
  • H. Dharmana, S. Saravana-Bawan, S. Girgis, and G. Low, “Hepatocellular adenoma: imaging review of the various molecular subtypes,” Clinical Radiology, 2017. View at Publisher · View at Google Scholar
  • Safi Dokmak, Béatrice Aussilhou, Fanjandrainy Rasoaherinomenjanahary, Maxime Ronot, Rafik Dahdouh, Fadhel S. Ftériche, François Cauchy, Valérie Paradis, Jacques Belghiti, and Olivier Soubrane, “Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery,” Hpb, 2018. View at Publisher · View at Google Scholar
  • Elizabeth D. Brooks, Dustin J. Landau, Jeffrey I. Everitt, Talmage T. Brown, Kylie M. Grady, Lauren Waskowicz, Cameron R. Bass, John D’Angelo, Yohannes G. Asfaw, Kyha Williams, Priya S. Kishnani, and Dwight D. Koeberl, “Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy,” Journal of Inherited Metabolic Disease, 2018. View at Publisher · View at Google Scholar
  • Hyo Jeong Kang, Hui Jeong Jeong, So-Woon Kim, Eunsil Yu, Young-Joo Lee, So Yeon Kim, and Jihun Kim, “Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia,” Journal of Pathology and Translational Medicine, vol. 52, no. 4, pp. 226–231, 2018. View at Publisher · View at Google Scholar
  • Amedeo Sciarra, Sabine Schmidt, Alessandro Pellegrinelli, Marco Maggioni, Daniele Dondossola, Jerome Pasquier, Claudia Cigala, Delfina Tosi, Nermin Halkic, Gaetano Bulfamante, Giuseppe Viale, Silvano Bosari, Charles Balabaud, Paulette Bioulac-Sage, and Christine Sempoux, “OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy,” Liver International, 2018. View at Publisher · View at Google Scholar
  • Antonio Costantino, and Tamar H. Taddei, “Primary Liver Tumors Other than Hepatocellular Carcinoma: Clinical and Molecular Pearls,” Current Hepatology Reports, 2018. View at Publisher · View at Google Scholar
  • Safi Dokmak, “Pathological Classification and Surgical Approach to Hepatocellular Adenomas,” Primary and Metastatic Liver Tumors, pp. 153–167, 2018. View at Publisher · View at Google Scholar
  • Matteo Garcovich, Mariella Faccia, Franca Meloni, Emanuela Bertolini, Ilario de Sio, Giosuele Calabria, Giampiero Francica, Gianpaolo Vidili, Laura Riccardi, Maria Assunta Zocco, Maria Elena Ainora, Francesca Romana Ponziani, Anna Maria De Gaetano, Antonio Gasbarrini, Gian Ludovico Rapaccini, and Maurizio Pompili, “Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience,” Journal of Ultrasound, 2018. View at Publisher · View at Google Scholar
  • Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano, and Aileen Wee, “Tumours and Tumour-like Lesions of the Liver,” Macsween's Pathology of the Liver, pp. 780–879, 2018. View at Publisher · View at Google Scholar